Isabelle Racamier, MIM, is Chief Executive Officer of EsoCap AG. Isabelle Racamier is an accomplished healthcare executive in the biopharmaceutical industry.
She also leads Arlys Consulting, a management consultancy advising innovative and growth-oriented companies in the Life Sciences field.
Isabelle Racamier has 25 years of experience in the pharmaceutical and biotechnology industries, in controlling, strategic planning, marketing and general management. Isabelle Racamier has held increasingly responsible positions in France, Switzerland, the USA, Japan and Austria with Novartis, Boehringer Mannheim (now part of Roche) and Sanofi. She was the General Manager of Sanofi in Austria from 1998 to 2005, consistently generating yearly double-digit growth during this time. Isabelle Racamier served as a Board member of the Franco-Austrian Chamber of Commerce from 2002 to 2009.
Since 2016 Isabelle Racamier is a member of the Supervisory Board of Genomic Vision, a molecular diagnostic company listed on the French stock exchange. In July 2018 she has been appointed President of the Supervisory Board.
Isabelle Racamier earned her Master’s in Management from ESCP-Europe in Paris. She received executive training in Marketing at INSEAD.